Connect with us

Technology

Instagram revamps its mobile messaging app Threads – Yahoo Finance Australia

Instagram is continuing to develop its standalone messaging app, Threads. Last month, the company modified the app to make it possible for users to message…

Published

on

post featured image

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational and financial results for the first quarter ended September 30, 2020 (FY2021). Mesoblast has entered into an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of its lead mesenchymal stromal cell (MSC) product candidate, remestemcel-L, with…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending